Roquefort Therapeutics plc (ROQ.L)
GBp 3.85
(-10.47%)
GBp 3.85
(-10.47%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.12 Million GBP | 30.32% |
| 2022 | 1.63 Million GBP | 225.94% |
| 2021 | 501.41 Thousand GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 331.09 Thousand GBP | 170.64% |
| 2024 Q2 | 331.09 Thousand GBP | 0.0% |
| 2023 Q4 | -468.71 Thousand GBP | -194.1% |
| 2023 FY | 2.12 Million GBP | 30.32% |
| 2023 Q3 | 498.1 Thousand GBP | -56.16% |
| 2023 Q2 | 1.13 Million GBP | 99.79% |
| 2023 Q1 | 568.71 Thousand GBP | -45.9% |
| 2022 Q1 | 381.14 Thousand GBP | 90.4% |
| 2022 Q4 | 1.05 Million GBP | 141.08% |
| 2022 FY | 1.63 Million GBP | 225.94% |
| 2022 Q3 | 436.01 Thousand GBP | -25.23% |
| 2022 Q2 | 583.16 Thousand GBP | 53.0% |
| 2021 Q4 | 200.18 Thousand GBP | 0.0% |
| 2021 Q2 | 301.23 Thousand GBP | 100.0% |
| 2021 Q1 | 150.61 Thousand GBP | 1889.91% |
| 2021 FY | 501.41 Thousand GBP | 0.0% |
| 2020 Q4 | 7569.00 GBP | 0.0% |
| 2020 Q3 | 7569.00 GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|